We have no idea what the deal is with our distributor or how much we can ramp up production. If we can't ramp up production (unlikely given the worldwide demand) then we're at $2 billion revenue most likely $500 million earnings with increased trials. $500 million x 20 P/E = $10 billion market cap. With increased production, upcoming catalysts and the sheer potential it should be much higher.